IRIS
SILVESTRO, MARCELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.935
AS - Asia 1.116
NA - Nord America 650
SA - Sud America 183
AF - Africa 13
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.901
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.192
US - Stati Uniti d'America 624
SG - Singapore 471
IT - Italia 251
CN - Cina 235
IE - Irlanda 206
BR - Brasile 151
HK - Hong Kong 141
VN - Vietnam 86
DE - Germania 85
GB - Regno Unito 57
KR - Corea 56
JP - Giappone 49
IN - India 29
FI - Finlandia 26
CA - Canada 19
AT - Austria 18
SE - Svezia 17
GR - Grecia 16
AR - Argentina 14
CZ - Repubblica Ceca 14
UA - Ucraina 11
BE - Belgio 10
BD - Bangladesh 8
ES - Italia 8
FR - Francia 6
NL - Olanda 6
PK - Pakistan 6
IQ - Iraq 5
CO - Colombia 4
EC - Ecuador 4
ID - Indonesia 4
IR - Iran 4
MX - Messico 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
PY - Paraguay 3
TR - Turchia 3
ZA - Sudafrica 3
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
KE - Kenya 2
LV - Lettonia 2
MA - Marocco 2
MT - Malta 2
PL - Polonia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NR - Nauru 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.901
Salva come PNG Salva come JPEG
Città #
Moscow 1.190
Singapore 210
Dublin 206
Hong Kong 141
Santa Clara 132
Naples 66
Chandler 56
Seoul 56
Ashburn 50
Hefei 41
Beijing 38
Munich 38
Ho Chi Minh City 29
Jacksonville 26
Roxbury 26
Princeton 25
Bremen 24
Hanoi 22
Dallas 20
Bengaluru 19
The Dalles 19
Medford 18
New York 17
Brno 13
Helsinki 13
São Paulo 13
Los Angeles 12
Aversa 11
Turku 10
Vienna 10
Caserta 9
Des Moines 9
Reggio Emilia 9
Cambridge 8
Milan 8
Viterbo 8
Belo Horizonte 7
Boardman 7
Hasselt 7
Nanjing 7
Napoli 7
Nuremberg 7
Atlanta 5
Bologna 5
Brooklyn 5
Falkenstein 5
Hebei 5
London 5
Montreal 5
Norwalk 5
San Francisco 5
Stockholm 5
Tokyo 5
Wilmington 5
Amsterdam 4
Avella 4
Curitiba 4
Dhaka 4
Guangzhou 4
Guarulhos 4
Sacramento 4
Salerno 4
Shenyang 4
Tashkent 4
Ann Arbor 3
Biên Hòa 3
Boston 3
Brussels 3
Chennai 3
Da Nang 3
Florence 3
Haiphong 3
Ninh Bình 3
Phoenix 3
Porto Alegre 3
Rio de Janeiro 3
São Leopoldo 3
Toronto 3
Villaricca 3
Adrogué 2
Afragola 2
Alexandria 2
Belpasso 2
Brasília 2
Campinas 2
Canoas 2
Caruaru 2
Castellammare di Stabia 2
Catania 2
Cerquilho 2
Chicago 2
Columbus 2
Formosa 2
Frankfurt am Main 2
Giugliano in Campania 2
Hangzhou 2
Houston 2
Hải Dương 2
Indore 2
Islamabad 2
Totale 2.831
Salva come PNG Salva come JPEG
Nome #
A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG 156
Cluster headache pathophysiology: What we have learned from advanced neuroimaging 156
Telemedicine application to headache: a critical review 149
Can Craniometry Play a Role in Cluster Headache Diagnosis? A Pilot Exploratory TC-3D Based Study 142
Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura 139
Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease 137
Cognitive, behavioral, and brain functional connectivity correlates of fatigue in amyotrophic lateral sclerosis 135
Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder 130
Infodemiology of cluster headache seasonality: A proof of concept by a Google Trends analysis 125
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 125
Arterial spin labeling MRI applied to migraine: current insights and future perspectives 123
Advances in migraine neuroimaging and clinical utility: from the MRI to the bedside 122
Resting state fMRI analysis of pseudobulbar affect in Amyotrophic Lateral Sclerosis (ALS): motor dysfunction of emotional expression 119
Effectiveness and safety of CGRP monoclonal antibodies in migraine related to mitochondrial diseases in patients with NARP and PEO syndromes 113
Coping Strategies in Migraine without Aura: A Cross-Sectional Study 113
Disconnectome of the migraine brain: a "connectopathy" model 110
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience 109
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 107
The "Cluster-SUNCT Syndrome": The Lumper-Splitter Problem 106
Readability Analysis of Online Headache and Migraine Information 101
Reduced neurovascular coupling of the visual network in migraine patients with aura as revealed with arterial spin labeling MRI: is there a demand-supply mismatch behind the scenes? 100
The conundrum of relationship between pain and visual pathway in migraine with aura 100
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience 98
Psychological Support for Family Caregivers of Patients With Amyotrophic Lateral Sclerosis at the Time of the Coronavirus Disease 2019 Pandemic: A Pilot Study Using a Telemedicine Approach 97
Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment 93
Validation of new diagnostic criteria for fatigue in patients with Parkinson disease 92
Emerging drugs for the preventive treatment of migraine: a review of CGRP monoclonal antibodies and gepants trials 91
Headache Worsening after COVID-19 Vaccination: An Online Questionnaire-Based Study on 841 Patients with Migraine 90
The "Ram's Horns Sign": A Case Report of an Unusual Side Effect of OnabotulinumtoxinA in a Chronic Migraine Patient 88
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients 87
Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults 87
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia 85
Migraine in the Time of COVID-19 85
SUNCT-Induced Jaw Opening: A Rare Trigeminal Autonomic Phenotype 85
Erenumab Efficacy on Comorbid Cluster Headache in Patients With Migraine: A Real-World Case Series 84
Screening of visuospatial abilities in amyotrophic lateral sclerosis (ALS): a pilot study using the battery for visuospatial abilities (BVA) 82
Functional neuroimaging biomarkers in migraine: diagnostic, prognostic and therapeutic implications 81
Migraine as a Cortical Brain Disorder 81
Recent Insights in Migraine With Aura: A Narrative Review of Advanced Neuroimaging 78
Perceived ease-of-usability and local tolerability using CGRP monoclonal antibody autoinjectors vs. syringes: an online questionnaire-based study in patients with migraine 77
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience 72
Pain Perception and Migraine 69
A case of rapidly progressive juvenile amyotrophic lateral sclerosis associated with a pathogenetic heterozygous de novo variant in the FUS gene 68
Functional connectivity changes in complex migraine aura: beyond the visual network 68
Shedding light on migraine with aura: the clarifying role of advanced neuroimaging investigations 67
"Forced Normalization": Could It Occur Also in Migraine Patients? 66
Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients 65
Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine 61
Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study 61
Migraine Treatment: Towards New Pharmacological Targets 60
A 67-Year-Old Woman With Recurrent Headache, Migratory Focal Symptoms, and Impaired Consciousness 59
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 56
Evidence-based guidelines for the pharmacological treatment of migraine 55
Evidence-based guidelines for the pharmacological treatment of migraine, summary version 54
Excellent Response to OnabotulinumtoxinA: Different Definitions, Different Predictors 53
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) 52
The relevance of cortical thickness in migraine sufferers and implications to therapy 51
No additional benefit with detoxification strategies: A real world experience in 200 patients with chronic migraine and either simple or complex MOH treated with CGRP monoclonal antibodies 51
Monoclonal antibodies targeting the calcitonin gene-related peptide pathway improve the effectiveness of acute medication—a real-world study 46
Refractory migraine profile in CGRP-monoclonal antibodies scenario 46
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 44
OnabotulinumtoxinA in elderly patients with chronic migraine: insights from a real-life European multicenter study 43
Functional Changes of the Perigenual Part of the Anterior Cingulate Cortex after External Trigeminal Neurostimulation in Migraine Patients 42
Migraine Does Not Affect Pain Intensity Perception: A Cross-Sectional Study 42
Prospective memory is dysfunctional in migraine without aura 42
Safety of Onabotulinumtoxin-A for Chronic Migraine During Pregnancy and Breastfeeding: A Narrative Review 42
Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence 39
Sex differences in the clinical features of 2,841 patients with migraine: a post-hoc, multicenter, cross-sectional study 36
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men 35
Pain-Related Brain Connectivity Changes in Migraine: A Narrative Review and Proof of Concept about Possible Novel Treatments Interference 34
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study 31
Exploring the multifaceted characteristics of aura in migraine: A multicenter, cross-sectional study 31
Idiopathic hypertrophic pachymeningitis mimicking hemicrania continua: An unusual clinical case 29
Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study 26
Physiopathology of Migraine: What Have We Learned from Functional Imaging? 25
Totale 5.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.554
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 1 13 7 1 5 13 3
2021/2022210 11 5 9 12 65 8 3 5 6 9 22 55
2022/2023339 40 12 6 18 43 13 0 15 174 2 13 3
2023/2024237 11 19 11 13 60 28 10 10 6 4 16 49
2024/2025817 1 20 12 21 154 76 104 63 140 83 91 52
2025/20264.238 167 211 182 174 534 2.970 0 0 0 0 0 0
Totale 5.999